Social Icons

Showing posts with label mcx tips. Show all posts
Showing posts with label mcx tips. Show all posts

Saturday 16 June 2018

expr:content='data:blog.blogId' itemprop='blogId'/>

Dalal Street week ahead: Bank Nifty, FMCG, pharma should do better now

capitalstars


In our weekly note last week, we had discussed about the likelihood of the Nifty attempting to move past its falling trend line resistance, which joins the lower tops.

In the week gone by, the benchmark index struggled throughout to move past this pattern area resistance but could not make any clear headway on the upside. The pullback seen on the last trading session of the week helped the Nifty index close the week with a gain of 50.05 points, or 0.46 per cent.

However, though this may restrict and resist the immediate upward move in the present context, but the RSI is seen trying to break out of a pattern formation. The weekly MACD is bullish as it trades above the signal line. No significant formations were observed on the candles. 
Next week is going to be critical for the markets as Nifty moving past the pattern resistance of the trend line joining a probable lower tops will be very important. We expect the market to remain rangebound. F&O data suggests the range might get a little broader, but downsides will certainly remain capped.

The coming week is likely to see the market turn highly stock and sector specific. One should continue to guard profits at higher levels. Shorts should be avoided, unless some critical supports are breached, as the undercurrent continues to be buoyant. 

A study of Relative Rotation Graphs shows PSU banks have further improved in terms of their relative momentum and are expected to continue this trajectory in the coming weeks as well. Along with this, the Bank NIFTY pack has moved into the leading quadrant and is expected to outperform on a relative basis. It is likely to have the company of the financial services sector, which is also expected to outperform. 

The FMCG pack is likely to do well but performance may remain stock specific. Apart from this, the pharma pack is expected to put up a better show on the relative momentum front. Broader indices such as CNX 100, CNX 200 and CNX 500 will continue on the falling trajectory and this may check any runaway rise in the broader market. Auto, midcaps, smallcaps and Nifty Next 50 continue to deteriorate on the momentum front. No show is expected from the media pack. IT and realty may see sporadic outperformance.


visit us: www.capitalstars.com/


call on:9977499927

O731-6690000

Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Friday 15 June 2018

expr:content='data:blog.blogId' itemprop='blogId'/>

CAPITALSTARS-CORPORATE NEWS


capitalstars

Dr. Reddy's launches gSuboxone
Dr Reddy Lab Dr. Reddy's Laboratories has announced that it is launching generic of Buprenorphine and Naloxone Sublingual Film (Suboxone) following a final USFDA approval in the US market.
The product is being launched with USFDA’s approved Risk Evaluation and Mitigation Strategy (REMS) Program. US Company, Mylan has also launched this drug in the US market. Considering that the patent on this drug is still valid, this is at risk launch.
Buprenorphine and naloxone are used to treat adults with opioid dependence/addiction. The combination of these medications is used as part of a complete treatment program including prescription monitoring, counselling, and psychosocial support. The launch has been very important as per the USFDA’s recent statements indicating increasing opioid addiction in America.

Maruti Suzuki likely to bid adieu to Ignis Diesel variant
India’s largest passenger vehicle (PV) manufacturer Maruti Suzuki India Limited (MSIL) is likely to stop production of diesel variant of its hatchback Ignis, as per media reports. The Ignis was launched in January 2017 with both variants – petrol and diesel. While the petrol variant will be retained, diesel version will be likely discontinued. Several reasons could be responsible for the decision.
Firstly, the steep pricing proved to be a deterrent. While the petrol Ignis is priced between Rs4.66Lakh and Rs6.51Lakh, the diesel variant ranges between Rs6.32Lakh and Rs8.12Lakh (ex-showroom price in New Delhi as per website www.cardekho.com). Secondly, consumers are increasingly sceptical of owning diesel cars given that price difference between diesel and petrol in the retail market (fuel pumps) is narrowing. As per media reports, about 90% of Ignis models sold so far have been petrol variants and only 10% have been diesel variants. Lastly, it makes more sense for MSIL to free up capacity for its best-selling models rather than continuing with laggards.

Avanti Feeds surges after shareholders approve stock split
Avanti Feeds registered gains at the equity market after it announced its decision to sub-divide equity shares from face value of Rs2 each to Rs1 each. Further, it decided to issue bonus equity shares of Rs1 each in the ratio of 1:2, that is, one equity share of Rs1 each for every two and equity shares of Rs1 each (after sub-division of shares). Shareholders approved this recommendation with the requisite majority.This could be good news for the company.
The company is a leading manufacturer and exporter of shrimp feeds and shrimp processor. It also operates wind mill with an installed capacity of ~3.2 megawatt in Karnataka. It derived ~83% revenue from shrimp feeds and ~17% revenue from processed shrimp during FY18. The total feed capacity stands at six lakh tonnes per annum as on March 31, 2018.

Alembic Pharma rises on getting EIR from USFDA for Panelav unit
Alembic Pharmaceuticals Alembic Pharmaceuticals is currently trading at Rs520.35 up by Rs13.8 or 2.72% from its previous closing of Rs506.55 on the BSE. The pharma company said it received establishment inspection report (EIR) from USFDA for the inspection carried out by them at the company’s formulation facility at Panelav during the period from March 1, 2018 to March 20, 2018.
On Thursday, the firm announced during trading hours that day that it has received approval from USFDA for its ANDA for Doxycycline Hyclate capsules USP, 50mg and 100mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vibramycin capsules, 50mg and 100mg, of Pfizer Inc.

NBCC bags contracts worth Rs480.6cr in May
NBCC NBCC (India) is currently trading at Rs85.50 up by Rs0.2 or 0.23% from its previous closing of Rs85.30 on the BSE.
The company has secured the total business of Rs480.65cr (approx) in the month of May, 2018.
NBCC is a Navratna PSU engaged in the business of project management consultancy (PMC), real estate and EPC. PMC and redevelopment comprises 87%, real estate and EPC forms 13% of the company’s order book. Through PMC, the company has been executing many landmark projects.


visit us: www.capitalstars.com/


call on:9977499927

O731-6690000

Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647



Tuesday 12 June 2018

expr:content='data:blog.blogId' itemprop='blogId'/>

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 12 JUNE 2018

capitalstars


CS OPENING BELL:
NIFTY SPOT UP 7 @ 10795
SENSEX UP 14 @ 35496
BANK NIFTY FUTURES DOWN 17 @ 26460
                                                                                          HAPPY TRADING!!!!!!!!!!!


CS NIFTY FUTURES (JUNE ) OVERVIEW

TREND BULLISH
RES2: 10920
RES 1:10875
SUP1:10725
SUP2:10640

CS BANK NIFTY FUTURES (JUNE ) OVERVIEW

TREND BULLISH
RES 2: 26925
RES 1: 26765
SUP1: 26320
SUP2: 26130

visit us: www.capitalstars.com/


call on:9977499927

O731-6690000

Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Monday 11 June 2018

expr:content='data:blog.blogId' itemprop='blogId'/>

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 11 JUNE 2018

capitalstars

CS OPENING BELL:
NIFTY SPOT UP 60 @ 10827
SENSEX UP 200 @ 35642
BANK NIFTY FUTURES UP 187 @ 26625


                                                                                               HAPPY TRADING!!!!!!!!!!!
CS NIFTY FUTURES (JUNE ) OVERVIEW

TREND BULLISH
RES2: 10950
RES 1:10875
SUP1:10710
SUP2:10640

 CS BANK NIFTY FUTURES (JUNE ) OVERVIEW

TREND BULLISH
RES 2: 27060
RES 1: 26800
SUP1: 26285
SUP2: 26080


visit us: www.capitalstars.com/

call on:9977499927

O731-6690000

Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Friday 8 June 2018

expr:content='data:blog.blogId' itemprop='blogId'/>

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 08 JUNE 2018

capitalstars

CS OPENING BELL:
NIFTY SPOT DOWN 25 @ 10744
SENSEX DOWN 78 @ 35385
BANK NIFTY FUTURES DOWN 209 @ 26357
                                                                                     HAPPY TRADING!!!!!!!!!!!


CS NIFTY FUTURES (JUNE ) OVERVIEW

TREND BEARISH
RES2: 10850
RES 1:10785
SUP1:10640
SUP2:10560


CS BANK NIFTY FUTURES (JUNE ) OVERVIEW

TREND BULLISH
RES 2: 26800
RES 1: 26635
SUP1: 26135
SUP2: 26920


 visit us: www.capitalstars.com/

call on:9977499927

O731-6690000

Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Thursday 7 June 2018

expr:content='data:blog.blogId' itemprop='blogId'/>

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 07 JUNE 2018

capitalstars
CS OPENING BELL:
NIFTY SPOT UP 76 @ 10760
SENSEX UP251 @ 35430
BANK NIFTY FUTURES UP 199 @ 26590
                                                                                 HAPPY TRADING!!!!!!!!!!!


CS NIFTY FUTURES (JUNE ) OVERVIEW

TREND BULLISH
RES2: 10875
RES 1:10830
SUP1:10670
SUP2:10630



CS BANK NIFTY FUTURES (JUNE ) OVERVIEW

TREND BULLISH
RES 2: 26925
RES 1: 26765
SUP1: 26340
SUP2: 26080

 visit us: www.capitalstars.com/

call on:9977499927

O731-6690000

Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647


Wednesday 6 June 2018

expr:content='data:blog.blogId' itemprop='blogId'/>

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 06 JUNE 2018



CS OPENING BELL:
NIFTY SPOT DOWN 47 @ 10635
SENSEX DOWN 176 @ 34980
BANK NIFTY FUTURES DOWN  120 @ 25952
                                                                               HAPPY TRADING!!!!!!!!!!!


CS NIFTY FUTURES (JUNE) OVERVIEW

TREND BEARISH
RES2: 10765
RES 1:10700
SUP1:10540
SUP2:10455

CS BANK NIFTY FUTURES (JUNE) OVERVIEW

TREND BEARISH
RES 2: 26565
RES 1: 26430
SUP1: 26020
SUP2: 25810

 visit us: www.capitalstars.com/




call on:9977499927

O731-6690000

Get more details here:-


* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647



Tuesday 5 June 2018

expr:content='data:blog.blogId' itemprop='blogId'/>

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 05 JUNE 2018

capitalstars


CS OPENING BELL:
NIFTY SPOT DOWN 30 @ 10598
SENSEX DOWN 70 @ 34943
BANK NIFTY FUTURES UP  53@ 26243
HAPPY TRADING!!!!!!!!!!!


CS NIFTY FUTURES (MAY ) OVERVIEW

TREND BULLISH
RES2: 10735
RES 1:10675
SUP1:10515
SUP2:10455

CS BANK NIFTY FUTURES (MAY ) OVERVIEW

TREND BULLISH
RES 2: 26635
RES 1: 26500
SUP1: 25950
SUP2: 25720


 visit us: www.capitalstars.com/



call on:9977499927

O731-6690000

Get more details here:-


* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647



Thursday 31 May 2018

expr:content='data:blog.blogId' itemprop='blogId'/>

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 31 MAY 2018

CAPITALSTARS

CS OPENING BELL:
NIFTY SPOT UP 23 @ 10637
SENSEX UP 94  @ 34999
BANK NIFTY FUTURES UP 134 @ 26385

                                                                           HAPPY TRADING!!!!!!!!!!!
CS NIFTY FUTURES (MAY ) OVERVIEW

TREND BULLISH
RES2: 10815
RES 1:10745
SUP1:10585
SUP2:10500

CS BANK NIFTY FUTURES (MAY ) OVERVIEW

TREND BULLISH
RES 2: 26925
RES 1: 26760
SUP1: 26240
SUP2: 26135


 visit us: www.capitalstars.com/


call on:9977499927

O731-6690000

Get more details here:-


* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Tuesday 29 May 2018

expr:content='data:blog.blogId' itemprop='blogId'/>

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 29 MAY 2018

capitalstars

CS OPENING BELL:
NIFTY SPOT DOWN 20 @ 10667
SENSEX DOWN 62 @ 35100
BANK NIFTY FUTURES DOWN 140 @ 26402

                                                               HAPPY TRADING!!!!!!!!!!!

CS NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH
RES2: 10815
RES 1:10745
SUP1:10590
SUP2:10520

CS BANK NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH
RES 2: 26765
RES 1: 26635
SUP1: 26240
SUP2: 26135

visit us: www.capitalstars.com/

call on:9977499927

O731-6690000

Get more details here:-


* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647


Saturday 26 May 2018

expr:content='data:blog.blogId' itemprop='blogId'/>

capitalstars news update-IHH extends validity of its `Enhanced Revised offer` for Fortis till June 30

capitalstars

Fortis Healthcare (FHL) on Friday said that Malaysia's IHH Healthcare Berhad has extended the validity of its "Enhanced Revised Offer" to invest in the company.
As per a BSE filing, FHL said that its Board has received a letter from IHH for extending the acceptance period for its offer to June 30 from the earlier date of May 29. IHH has proposed to invest directly into the company at Rs 175 per share cost.
"In order to enable the reconstituted Board to fully consider and evaluate our proposal, we now extend the acceptance period of the enhanced revised IHH proposal..." IHH Healthcare Berhad's Managing Director and Group CEO Tan See Leng said in the letter to the Fortis Board.
The development comes just after a consortium of Manipal-TPG had extended the validity of its "modified" new offer till June 6 from the earlier date of May 29.
"We understand that the FHL board is still in the process of considering the modified new offer... in order to provide FHL board with sufficient time to consider our modified new offer, we propose to extend the validity of our modified new offer...," the Manipal Global Health Services said in a letter to the company's Board.
On May 14, the Manipal-TPG consortium had received the "modified" new offer which proposed to values the company at Rs 9,403 crore at a share price of Rs 180 per share.
However, the company's Board on May 10 decided to recommend the offer of the Munjal-Burman consortium for sale of its business to the shareholders for their approval.
Fortis' board had received offers from suitors such as Hero Enterprise Investment Office, Burman Family Office, Fosun Health Holdings, Malaysia's IHH Healthcare Berhad, Manipal Hospital Enterprises and Radiant Life Care for infusion of funds.
In addition, the validity extension of IHH's offer comes as the healthcare major's shareholders voted Director Brian W. Tempest out from the company's Board at the Extraordinary General Meeting (EGM) held on Tuesday. The EGM had sought shareholders approval on a resolution filed by a minority shareholders' group to induct and remove certain Board members among other clearances.
The resolution had sought shareholders approval to replace Tempest, Non-Executive Director Harpal Singh, and Non-Executive Independent Directors Sabina Vaisoha and Tejinder Singh Shergill from the Board.
Harpal Singh, Shergill, and Vaisoha resigned on Sunday citing personal reasons.
visit us: www.capitalstars.com/


call on:9977499927

O731-6690000


Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
 

Do U Want !!!!

Our Special Services

sensex-nifty-charts

 
Blogger Templates